FDA Approves Treatment for Ocular Pain Following Surgery

09:43 EST 4 Dec 2018 | Pharmaceutical Processing

News
Dextenza has the potential to replace a complex eye drop regimen that under the current standard of care requires up to 70 topical ocular steroid drops.
Contributed Author: 
Ocular Therapeutix, Inc.
Topics: 

Original Article: FDA Approves Treatment for Ocular Pain Following Surgery

More From BioPortfolio on "FDA Approves Treatment for Ocular Pain Following Surgery"